KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Raw Materials (2016 - 2025)

Historic Raw Materials for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $374.7 million.

  • Resmed's Raw Materials rose 271.89% to $374.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $374.7 million, marking a year-over-year increase of 271.89%. This contributed to the annual value of $367.3 million for FY2025, which is 329.44% up from last year.
  • Per Resmed's latest filing, its Raw Materials stood at $374.7 million for Q4 2025, which was up 271.89% from $363.4 million recorded in Q3 2025.
  • Over the past 5 years, Resmed's Raw Materials peaked at $468.8 million during Q1 2023, and registered a low of $145.4 million during Q1 2021.
  • Its 5-year average for Raw Materials is $358.7 million, with a median of $366.0 million in 2024.
  • Per our database at Business Quant, Resmed's Raw Materials soared by 13399.73% in 2022 and then tumbled by 2255.5% in 2024.
  • Resmed's Raw Materials (Quarter) stood at $322.6 million in 2021, then soared by 43.66% to $463.4 million in 2022, then grew by 0.82% to $467.2 million in 2023, then dropped by 21.92% to $364.8 million in 2024, then grew by 2.72% to $374.7 million in 2025.
  • Its Raw Materials was $374.7 million in Q4 2025, compared to $363.4 million in Q3 2025 and $367.3 million in Q2 2025.